(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $1.391
Issued: 14 Feb 2024 @ 11:10
Return: 1.37%
Previous signal: Feb 13 - 15:52
Previous signal:
Return: 4.59 %
Live Chart Being Loaded With Signals
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies...
Stats | |
---|---|
Today's Volume | 405 343 |
Average Volume | 988 330 |
Market Cap | 350.98M |
EPS | $0 ( 2024-03-19 ) |
Next earnings date | ( $-0.0900 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.62 |
ATR14 | $0.00500 (0.35%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-05 | Thomasian Harry Jr. | Buy | 135 714 | Common Stock |
2024-04-05 | Thomasian Harry Jr. | Sell | 67 389 | Common Stock |
2024-04-05 | Thomasian Harry Jr. | Buy | 135 714 | Restricted Stock Units |
2024-04-05 | Thomasian Harry Jr. | Sell | 135 714 | Restricted Stock Units |
2024-04-05 | Perez Jeffrey Thomas | Buy | 142 857 | Common Stock |
INSIDER POWER |
---|
34.55 |
Last 99 transactions |
Buy: 8 317 118 | Sell: 3 939 504 |
Volume Correlation
Precigen Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Precigen Inc Correlation - Currency/Commodity
Precigen Inc Financials
Annual | 2023 |
Revenue: | $6.23M |
Gross Profit: | $-4.74M (-76.18 %) |
EPS: | $-0.390 |
FY | 2023 |
Revenue: | $6.23M |
Gross Profit: | $-4.74M (-76.18 %) |
EPS: | $-0.390 |
FY | 2022 |
Revenue: | $26.91M |
Gross Profit: | $20.57M (76.44 %) |
EPS: | $-0.400 |
FY | 2021 |
Revenue: | $103.87M |
Gross Profit: | $45.49M (43.79 %) |
EPS: | $-0.470 |
Financial Reports:
No articles found.
Precigen Inc
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators